Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 19158832)

1.

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.

Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S, Bruennert D, Huenerlituerkoglu AN, Stoecklein NH, Singh R, Zerbini LF, Jäger M, Kobbe G, Gattermann N, Kronenwett R, Brors B, Haas R.

Leukemia. 2009 May;23(5):892-9. doi: 10.1038/leu.2008.392. Epub 2009 Jan 22.

PMID:
19158832
2.

Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.

Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M, Brors B, Pechtel S, Bork S, Koch A, Baer A, Rohr UP, Kobbe G, von Haeseler A, Gattermann N, Haas R, Kronenwett R.

Leukemia. 2007 Mar;21(3):494-504. Epub 2007 Jan 25.

PMID:
17252012
3.

Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources.

Graham SM, Vass JK, Holyoake TL, Graham GJ.

Stem Cells. 2007 Dec;25(12):3111-20. Epub 2007 Aug 23.

4.

Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.

Carlo-Stella C, Dotti G, Mangoni L, Regazzi E, Garau D, Bonati A, Almici C, Sammarelli G, Savoldo B, Rizzo MT, Rizzoli V.

Blood. 1996 Oct 15;88(8):3091-100.

5.

Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.

Kronenwett R, Butterweck U, Steidl U, Kliszewski S, Neumann F, Bork S, Blanco ED, Roes N, Gräf T, Brors B, Eils R, Maercker C, Kobbe G, Gattermann N, Haas R.

Oncogene. 2005 Aug 11;24(34):5313-24.

PMID:
15806158
6.
7.

Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.

Moore S, Haylock DN, Lévesque JP, McDiarmid LA, Samels LM, To LB, Simmons PJ, Hughes TP.

Blood. 1998 Oct 1;92(7):2461-70.

8.

Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.

Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R.

Blood. 1993 Feb 1;81(3):801-7.

9.

Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.

Primo D, Flores J, Quijano S, Sanchez ML, Sarasquete ME, del Pino-Montes J, Gaarder PI, Gonzalez M, Orfao A.

Br J Haematol. 2006 Oct;135(1):43-51. Epub 2006 Aug 25.

PMID:
16939497
10.

ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.

Sun B, Jiang G, Zaydan MA, La Russa VF, Safah H, Ehrlich M.

Cancer Res. 2001 Sep 15;61(18):6931-7.

11.

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB.

Blood. 1996 Jun 1;87(11):4770-9.

12.

BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.

Grand FH, Marley SB, Chase A, Titley I, Healy L, Spencer A, Reiter A, Goldman JM, Gordon MY.

Leukemia. 1997 Sep;11(9):1486-92.

PMID:
9305602
13.

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.

Lemoli RM, Salvestrini V, Bianchi E, Bertolini F, Fogli M, Amabile M, Tafuri A, Salati S, Zini R, Testoni N, Rabascio C, Rossi L, Martin-Padura I, Castagnetti F, Marighetti P, Martinelli G, Baccarani M, Ferrari S, Manfredini R.

Blood. 2009 Dec 10;114(25):5191-200. doi: 10.1182/blood-2008-08-176016. Epub .

14.

Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.

Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.

Cancer Res. 2000 Feb 1;60(3):610-7.

15.

Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.

Misawa M, Maeda H, Hara H, Yamamoto Y, Furuyama J.

Stem Cells. 1993 Nov;11(6):536-42.

PMID:
7509222
16.

Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.

Bhatia R, Munthe HA, Williams AD, Zhang F, Forman SJ, Slovak ML.

Exp Hematol. 2000 Dec;28(12):1401-12.

PMID:
11146162
17.

Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.

Van den Berg D, Wessman M, Murray L, Tong J, Chen B, Chen S, Simonetti D, King J, Yamasaki G, DiGiusto R, Gearing D, Reading C.

Blood. 1996 May 15;87(10):4348-57.

18.

Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.

Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.

Leuk Res. 2004 Jun;28(6):639-47.

PMID:
15120942
19.

BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia.

Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ.

Blood. 1993 Jun 1;81(11):2898-902.

20.

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.

Ohmine K, Ota J, Ueda M, Ueno S, Yoshida K, Yamashita Y, Kirito K, Imagawa S, Nakamura Y, Saito K, Akutsu M, Mitani K, Kano Y, Komatsu N, Ozawa K, Mano H.

Oncogene. 2001 Dec 13;20(57):8249-57.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk